Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

Annals of Neurology

Volumn 40, Issue 4, 1996, Pages 635-644

  Hafer Macko, Charlene ^a   Hsieh, Sung Tsang ^a   Yan Li, Chun ^c   Ho, Tony W ^a   Sheikh, Kazim ^a   Cornblath, David R ^a   McKhann, Guy M ^a,b   Asbury, Arthur K ^d   Griffin, John W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Second Teaching Hospital   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; MOTOR NEUROPATHY; NERVE FIBER MEMBRANE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AXONS; CAMPYLOBACTER JEJUNI; CHILD, PRESCHOOL; COMPLEMENT ACTIVATION; COMPLEMENT C3D; DEMYELINATING DISEASES; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NERVE DEGENERATION; SEVERITY OF ILLNESS INDEX;

EID: 0029859323     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400414     Document Type: Article

References (48)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215
2. Hafer-Macko C, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:453-463
3. Hughes RA, Rees JH. Guillain-Barré syndrome. Curr Opin Neurol 1994;7:386-392 (Review)
4. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
5. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192
6. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 1995;118:577-595
7. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28
8. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
9. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996;25:33-51
10. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
11. Coe CJ. Guillain-Barré syndrome in Korean children. Yonsei Med J 1989;30:81-87
12. Jackson CE, Barohn RJ, Mendell JR. Acute paralytic syndrome in three American men. Comparison with Chinese cases. Arch Neurol 1993;50:732-735
13. Ramos-Alvarez M, Bessudo L, Sabin A. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy: acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. JAMA 1969;207:1481-1492
14. Ho TW, Roberts M, Hsieh S-T, et al. Mechanism of paralysis and recovery in acute motor axonal neuropathy after Campylobacter jejuni infection, Ann Neurol 1995;38:350 (Abstract)
15. Gupta SK, Taly AB, Suresh TG, et al. Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation. Acta Neurol Scand 1994;89:220-224
16. Gregson NA, Jones D, Thomas PK, Willison HJ. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol 1991;238:447-451
17. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379
18. 1 antibodies following Campylobacter jejuni enteritis. Neurology 1990;40:1900-1902
19. Yuki N, Sato S, Fujimoto S, et al. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barre syndrome. Muscle Nerve 1992;16:968-969
20. Fujimoto S, Yuki N, Itoh T, Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis 1992;165:183 (Letter)
21. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994;35: 234-237
22. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816
23. Ganser AL, Kirschner DA. Differential expression of gangliosides on the surfaces of myelinated nerve fibers. J Neurosci Res 1984;12:245-255
24. Ganser AL, Kirschner DA, Willinger M. Ganglioside localization on myelinated nerve fibers by cholera toxin binding. J Neurocytol 1983;12:921-938
25. 1 antibodies, and multifocal motor conduction block. Ann Neurol 1990;28:373-377
26. Thomas FP, Trojaborg W, Nagy C, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 1991;82:378-383.
27. Yuki N, Handa S, Taki T, et al. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed Res 1992;13:451-453
28. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
29. Yuki N. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 1994;17:680-682
30. Powell HC, Myers RR. The axon in Guillain-Barré syndrome: immune target or innocent bystander? Ann Neurol 1996;39: 4-5 (Editorial)
31. Stoll G, Griffin JW, Li CY, Trapp BD. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989;18:671-683
32. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580
33. Law SK, Levine RP. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 1977;74:2701-2705
34. Lachmann PJ, Pangburn MK, Oldroyd RG. Breakdown of C3 after complement activation: identification of a new fragment, C3g, using monoclonal antibodies. J Exp Med 1982;156:205-216
35. a protein in Golgi complex membranes and myelin of developing rat Schwann cells. J Cell Biol 1981;90:1-6
36. Brechenmacher C, Vital C, Laurentjoye L, Castaing Y. Ultrastructural study of peripheral nerve in Guillain-Barré syndrome. Presence of mononuclear cells in axons. Acta Neuropathol 1981;7(suppl):249-251
37. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117
38. Willison HJ, Paterson G, Kennedy PG, Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol 1994;35:471-478
39. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect Immun 1994;62:2101-2103
40. Thomas FP, Adapon HP, Goldberg GP, et al. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease. J Neuroimmunol 1989;21:31-39
41. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809-814
42. Santoro M, Uncini A, Corbo M, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390
43. Illa I, Ortiz N, Gallard E, et al. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides, Ann Neurol 1995;38:218-224
44. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease? Ann Neurol 1995;37:436-442
45. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442
46. Roberts M, Willison H, Vincent A, Newsom-Davis J. Guillain-Barré syndrome and neurotransmitter release. Lancet 1994; 343:454-455 (Abstract)
47. Hirano A. Reaction of the periaxonal space to some pathological process. In: Zimmerman HM, ed. Progress in neuropathology, vol 5. New York: Raven Press, 1983:99-112
48. Trapp BD, Quarles RH, Suzuki K. Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal cytoplasmic collar of myelinating Schwann cells. J Cell Biol 1984;99:594-606